Nexien BioPharma, Inc. Stock Price - NXEN

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Nexien BioPharma, Inc. NXEN Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.00% 0.10 0.00 0.00 0.00 0.10 07:32:36
Bid Price Ask Price Spread Spread % News
0.0619 0.10 0.0381 38.10% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00 USD

Nexien BioPharma, Inc. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 5.35M 53.51M $ -1.28M - - 2.71M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
5.52k $ - 0.00% - -

more financials information »

Nexien BioPharma, Inc. News

Loading Messages....

Latest NXEN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NXEN Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week0.0903750.10.0903750.10004860.00962510.65%
1 Month0.10.10.0530.09993k0-
3 Months0.0650.10.0360.08955k0.03553.85%
6 Months0.124250.1980.0310.097917k-0.02425-19.52%
1 Year0.351.480.0310.267233k-0.25-71.43%
3 Years1.260.0310.334322k-1.1-91.67%
5 Years1.260.0310.334322k-1.1-91.67%

Nexien BioPharma, Inc. Description

Nexien BioPharma Inc. is a US-based pharmaceutical company engaged in the formulation, development and commercialization of cannabinoid-based pharmaceuticals, in accordance with U.S. Food and Drug Administration ('FDA') pre-clinical and clinical pathways, to address a broad range of medical conditions and disorders. Nexien BioPharma's drug development strategy consists of: A. The determination of medical conditions and disorders that could potentially benefit from cannabinoid-based formulations; B. Conducting "freedom to operate" investigations on these conditions; C. The preparation of patent applications and the prosecution of such application and/or the licensing of existing patents; D. Identifying the regulatory pathway with the FDA; and E. Proceeding with pre-clinical and clinical development activities in accordance with FDA protocols for submission to obtain approval for the particular product(s).

Your Recent History
Nexien Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.